8p deletions were marginally more frequent in ERG-positive cancers (40.9% according to IHC and 42.9% to FISH) than in ERG-negative cancers (34.7% according to IHC and 36.4% to FISH%, Figure 2A). This evidence concerns the gene ERG and cancer.